204 related articles for article (PubMed ID: 18462824)
1. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.
Barisani D; Pelucchi S; Mariani R; Galimberti S; Trombini P; Fumagalli D; Meneveri R; Nemeth E; Ganz T; Piperno A
J Hepatol; 2008 Jul; 49(1):123-33. PubMed ID: 18462824
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
Ravasi G; Pelucchi S; Trombini P; Mariani R; Tomosugi N; Modignani GL; Pozzi M; Nemeth E; Ganz T; Hayashi H; Barisani D; Piperno A
PLoS One; 2012; 7(5):e36425. PubMed ID: 22586470
[TBL] [Abstract][Full Text] [Related]
3. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
5. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
[TBL] [Abstract][Full Text] [Related]
9. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
Aigner E; Theurl I; Theurl M; Lederer D; Haufe H; Dietze O; Strasser M; Datz C; Weiss G
Am J Clin Nutr; 2008 May; 87(5):1374-83. PubMed ID: 18469261
[TBL] [Abstract][Full Text] [Related]
10. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
[TBL] [Abstract][Full Text] [Related]
11. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
12. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice.
Courselaud B; Troadec MB; Fruchon S; Ilyin G; Borot N; Leroyer P; Coppin H; Brissot P; Roth MP; Loréal O
Blood Cells Mol Dis; 2004; 32(2):283-9. PubMed ID: 15003819
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome.
Lainé F; Deugnier Y
Gastroenterology; 2006 Dec; 131(6):2028. PubMed ID: 17188970
[No Abstract] [Full Text] [Related]
14. Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
Gkouvatsos K; Wagner J; Papanikolaou G; Sebastiani G; Pantopoulos K
Hepatology; 2011 Nov; 54(5):1800-7. PubMed ID: 21748766
[TBL] [Abstract][Full Text] [Related]
15. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
[TBL] [Abstract][Full Text] [Related]
16. Iron-regulatory gene expression during liver regeneration.
Mollbrink A; Holmström P; Sjöström M; Hultcrantz R; Eriksson LC; Stål P
Scand J Gastroenterol; 2012 May; 47(5):591-600. PubMed ID: 22364558
[TBL] [Abstract][Full Text] [Related]
17. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin in iron overload disorders.
Papanikolaou G; Tzilianos M; Christakis JI; Bogdanos D; Tsimirika K; MacFarlane J; Goldberg YP; Sakellaropoulos N; Ganz T; Nemeth E
Blood; 2005 May; 105(10):4103-5. PubMed ID: 15671438
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of the iron metabolism].
Borch-Iohnsen B; Hagve TA; Hauge A; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):858-62. PubMed ID: 19415084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
